CaliPharms, Inc.

$0.00+0.00%(+$0.00)
TickerSpark Score
41/100
Weak
70
Valuation
60
Profitability
20
Growth
24
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KGET research report →

52-Week Range0% of range
Low $0.00
Current $0.00
High $0.01

Companywww.calipharmsinc.com

CaliPharms, Inc. engages in the medicinal Cannabis Industry in the United States. It focuses on the THC and CBD beverage industry.

CEO
Eric Watson
IPO
2013
Employees
4
HQ
Temecula, US

Price Chart

+0.00% · this period
$0.00$0.00$0.00Nov 23Nov 25May 20

Valuation

Market Cap
$11.86K
P/E
-0.01
P/S
0.99
P/B
-0.00
EV/EBITDA
-0.27
Div Yield
0.00%

Profitability

Gross Margin
100.00%
Op Margin
-11222.67%
Net Margin
-11861.40%
ROE
19.88%
ROIC
37.43%

Growth & Income

Revenue
$12.00K · 0.00%
Net Income
$-1,423,368 · -222.33%
EPS
$-0.00 · 0.00%
Op Income
$-1,346,720
FCF YoY
-1445.28%

Performance & Tape

52W High
$0.01
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
-58.74
Avg Volume
1.31M

Get TickerSpark's AI analysis on KGET

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our KGET Coverage

We haven't published any research on KGET yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate KGET Report →

Similar Companies